Table 2.

Multivariable regression model for platelet transfusion requirements during the first 60 days after HSCT

UnitsP
MedianRange
Transplant type    
 Nonmyeloablative (n = 40) 0 -214 —  
 Conventional (n = 67) 24 4 -358 < .001  
Risk for transfusions    
 Low (n = 65) 12 0 -214 —  
 High (n = 42) 28 0 -358 .01 
ABO compatibility    
 Compatible (n = 61) 12 0 -358 —  
 Major mismatch (n = 19) 24 0 -214 .14  
 Minor/minor and major mismatches (n = 27) 18 0 -172 .24  
No. of pretransplantation platelet transfusions: continuous variable   .01 
UnitsP
MedianRange
Transplant type    
 Nonmyeloablative (n = 40) 0 -214 —  
 Conventional (n = 67) 24 4 -358 < .001  
Risk for transfusions    
 Low (n = 65) 12 0 -214 —  
 High (n = 42) 28 0 -358 .01 
ABO compatibility    
 Compatible (n = 61) 12 0 -358 —  
 Major mismatch (n = 19) 24 0 -214 .14  
 Minor/minor and major mismatches (n = 27) 18 0 -172 .24  
No. of pretransplantation platelet transfusions: continuous variable   .01 

or Create an Account

Close Modal
Close Modal